Register to receive a free US Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices Market Report or a Europe Market Report Suite for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 synopsis and brochure
Soterix Medical, Inc. (SMI) recently announced that it had received Brazil’s National Health Surveillance Agency (ANVISA) approval for its products. This approval allows Soterix Medical to immediately begin marketing its products based on its proprietary transcranial Direct Current Stimulation (tDCS) technology in Brazil.
This announcement reflects Soterix Medical’s commitment to continue to deploy our innovative technology and medical treatments focused on neuropsychiatric and neurological disorders not just in select countries, but worldwide, said Mr. Renato Moratore, VP Regulatory Affairs of Soterix Medical. “We will work closely with our distributor to introduce our unique technology in Brazil.”
SMI has licensed and developed a comprehensive intellectual property portfolio that includes High-Definition transcranial Direct Current Stimulation (HD-tDCS), innovative tDCS technologies, and Neurotargeting software. From the most targeted non-invasive clinical systems to the most portable units, Soterix Medical provides clinicians and patients with unique and adaptable solutions. ANVISA approval also makes available Soterix Medical PainX™ and Depression-LTE™ treatment options which were already introduced in EU and Canada.
Ms. Pragya Bista, Product Engineer of Soterix Medical, added, “Our products stand out for their usability and Soterix Medical’s commitment to developing effective products for the clinic. The ANVISA approval allows us to bring our innovations directly to research and clinical centers across Brazil to advance tDCS research and treatment.”
CAUTION: tDCS is limited by Federal (or United States) law to investigational use only.
- HD-tES including HD-tDCS is the only technology platform that allows tolerated non-invasive delivery of therapeutic current to desired brain regions.
- tDCS-LTE is the only technology optimized for robust deployment in a wide variety of environments including emergency medicine, field-work, home-use, etc.
- Soterix Medical PainX™ and Depression-LTE™ Therapies are non-systemic (does not circulate in the bloodstream throughout the body) and non-invasive (does not involve surgery) form of Neuromodulation.
For Further Information
More on the neurology market can be found in our reports published by iData entitled the U.S. and Europe Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices Market, which covers market segments for Cerebrospinal Fluid Management, Intracranial Pressure Monitoring Devices, Detachable Coils, Liquid Embolics, Neurovascular Catheters, Neurovascular Guidewires, Neurovascular Stents, Neuromodulation Devices, Neuroendoscopes, Stereotactics, Ultrasonic Aspirators, Aneurysm Clips, Intrathecal Pumps, and Neurosurgery Robotic Assisted Surgery Systems.
The iData series on the market for neurology devices covers the United States, China, India, Japan and 15 Countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for a U.S. and Europe Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices Market brochure and synopsis.
About iData Research
iData Research is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ophthalmics, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Vascular Access, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Endoscopy, Anesthesiology, Wound Management, Orthopedics and more.
We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.